ArticleObesity surgery2026
Preoperative Triglyceride-Glucose Index as a Predictor of Weight Loss Following Sleeve Gastrectomy: A Retrospective Cohort Study.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe triglyceride-glucose (TyG) index is a simple and cost-effective surrogate marker of insulin resistance. While its role in predicting cardiometabolic risk is well established, its association with postoperative weight loss in bariatric surgery remains underexplored. This study aimed to evaluate the predictive value of the preoperative TyG index for weight loss outcomes following sleeve gastrectomy.
methodsIn this retrospective cohort study, data from 122 patients who underwent laparoscopic sleeve gastrectomy between January 2019 and January 2024 at a tertiary care center were analyzed. Preoperative TyG index values were calculated using fasting glucose and triglyceride levels. Patients were grouped based on a TyG cut-off value determined by ROC analysis. Associations between the TyG index and postoperative weight loss—both in absolute (kg) and percentage terms—were assessed using Pearson correlation and multivariable linear regression.
resultsThe mean TyG index was significantly higher in patients with greater postoperative weight loss (p < 0.05). ROC analysis identified a TyG cut-off of 8.7, which yielded a sensitivity of 75.4% and a specificity of 63.9% for predicting significant weight loss (AUC = 0.73). In multivariable analysis, the TyG index remained an independent predictor of postoperative weight loss after adjustment for age, sex, and BMI. Patients with TyG ≥ 8.7 demonstrated significantly higher absolute and percentage weight loss compared to those below this threshold.
conclusionThe preoperative TyG index is independently associated with postoperative weight loss outcomes in patients undergoing sleeve gastrectomy. Its ease of calculation and accessibility support its potential role as an adjunctive metabolic marker in preoperative counseling and risk stratification, rather than as a standalone tool for surgical decision-making. Prospective, multicenter studies are warranted to validate these findings and to clarify the clinical applicability of TyG-based thresholds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.